Press Releases | NeoGenomics Laboratories

As of November 1, 2020, we will discontinue future development for Internet Explorer

To have a better experience, please upgrade to Microsoft Edge, Google Chrome, or Firefox. Sorry for the convenience.

Presented: July 28, 2020

NeoGenomics Reports Revenue of $87 Million in the Second Quarter amid COVID-19 Pandemic

Presented: July 20, 2020

NeoGenomics Announces Board Appointments

Presented: July 1, 2020

NeoGenomics Schedules its Second Quarter Earnings Release for July 28, 2020

Presented: June 29, 2020

NeoGenomics Launches Comprehensive Suite of Solid Tumor Liquid Biopsy Tests for Cancer Patients

Presented: June 29, 2020

NeoGenomics To Virtually Present At The Raymond James Human Health Innovation Conference

Presented: June 2, 2020

NeoGenomics To Virtually Present At The Raymond James Human Health Innovation Conference

Presented: June 1, 2020

NeoGenomics To Virtually Participate In Fireside Chat At The 40th Annual William Blair Growth Stock Conference

Presented: May 26, 2020

NeoGenomics Enters Strategic Collaboration with Inivata to Commercialize InVisionFirst®-Lung Liquid Biopsy Test

Presented: May 26, 2020

NeoGenomics To Virtually Participate In 17th Annual Craig-Hallum Institutional Investor Conference

Presented: May 11, 2020

NeoGenomics To Virtually Participate In Fireside Chat At BofA Securities 2020 Health Care Conference

Presented: May 5, 2020

NeoGenomics and Bayer Collaborate to Offer NTRK Testing for Certain Colorectal and Thyroid Cancer Patients